SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CMTR-CHEMTRAK FDA OK

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: warren kaplan who wrote (491)3/13/1997 10:10:00 AM
From: William Presti   of 1172
 
If the FDA has it in for Chemtrak (which I seriously doubt) why then did they not drag their heels on the H.Pylori approvals we saw in both 1996 and 1997. And on what do you base your prediction that Astra-Merck will bail after fulfilling its contract? We have no reason to believe as much. Lastly, you mentioned about the company having serious problems, starting with Chairman Singh. That may have been somewhat true in the past only because he was in need of a true management team to take the company beyond R&D. Now they have one. So, I beg to differ with most of your comments. There is lots about CMTR which make it an attractive, albeit longterm, investment.

Aside from that, would anyone care to discuss how recent developments in the cholesterol-reducing drug arena could impact Cholestrak sales. Would be nice to see them team up with one of these drug companies in a mutually beneficial effort.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext